Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : AAV00500Z
Serotype : AAV Serotype 2 Storage : -80 ℃
Titer: Size:
| Cat. No. | AAV00500Z |
| Description | AAV serotype 2 particles express a fusion protein of optimized ChR2(H134R) and EYFP reporter under the control of human Synapsin promoter for neuronal specific expression and optogenetic activation. |
| Gene | ChR2(H134R)-YFP |
| Serotype | AAV Serotype 2 |
| Reporter | YFP |
| Applications |
1. Determination of optimal MOI (multiplicity of infection), administration methods etc. 2. Detection of the infection efficiency of the AAV serotype against a specific cell type or tissue. 3. Using reporter genes to visualize the distribution and expression of AAV vectors in live animals, helping assess the biodistribution and persistence of gene delivery. |
| Titer | Varies lot by lot, typically ≥1x10^12 GC/mL |
| Size | Varies lot by lot, for example, 30 μL, 100 μL, 500 μL etc. |
| Storage | Store at -80℃. Avoid multiple freeze/thaw cycles. |
| Shipping | Frozen on dry ice |
| Summary | Creative Biogene ensures high-quality AAV particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between AAV particle lots. |
| Endotoxin | Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in the production of AAV, especially for applications in animal studies and gene therapy. Effective endotoxin quality control is essential in the development and manufacturing of AAV particles. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced AAV particles to ensure regulatory compliance. |
| Purity | AAV purity is critical for ensuring the safety and efficacy of AAV-based applications.AAV capsids are composed of three main protein components, known as viral proteins: VP1, VP2, and VP3. These proteins play a critical role in the structure and functionality of the AAV capsid. Monitoring the VP1, VP2, and VP3 content in AAV preparations is essential for quality control in AAV production. Our AAV particles are tested for showing three clear bands of VP1, VP2 VP3 by SDS-PAGE. |
| Sterility | The AAV virus samples are inoculated into the cell culture medium for about 5 days to detect bacterial and fungal growth. |
| Transducibility | Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of AAV to deliver genetic material into target cells or tissues, and assess gene expression and functional activities. |
| Empty vs. Full Capsids | Based-on our proprietary AAV production and purification technology, Creative Biogene can always offer AAV particles with high ratio of full capsids. If required, we can also assess the ratio for a specifc lot of AAV particles by transmission electron microscopy (TEM) or other methods. |
Adeno-associated virus (AAV) is a member of the parvovirus family. Parvoviruses are the smallest of the DNA animal viruses, with a virion diameter of approximately 25nm and composed entirely of protein and DNA. AAV is classified as a dependent virus because it requires co-infection with a helper virus, such as adenovirus, herpes simplex virus (HSV), vaccinia virus, and human papillomavirus, for efficient infection. The AAV2 genome is a linear single-stranded DNA molecule containing 4679 nucleotides.
The wild-type (wt) AAV genome consists of two genes encoding four replication proteins, three capsid proteins, and an assembly activation protein, flanked by 145bp inverted terminal repeats. The larger replication proteins, Rep 78 and 68, are splice variants derived from the p5 promoter. Rep 68 and 78 have multiple functions and play a role in almost every aspect of the AAV life cycle, such as transcription, viral DNA replication, and site-specific integration into human chromosome 19. The small replication proteins Rep 40 and 52 are thought to be important for packaging of DNA into preformed viral capsids within the nucleus. The capsid structures of eight AAV serotypes have been resolved: AAV1, AAV2, AAV4, AAV5, AAV6, AAV7, AAV8, and AAV9. It is estimated that the three capsid proteins combine in a ratio of VP1:VP2:VP3 (1:1:10) to form the capsid.
The zona incerta (ZI) is a subthalamic structure implicated in locomotion, fear, and anxiety. Although evidence suggests an anatomical connection between the ZI and the inferior olive (IO) and pontine nuclei (PN), how the ZI modulates neuronal activity in these regions remains to be determined. The researchers first tested this by monitoring the responses of single neurons in the PN and IO to optogenetic activation of channelrhodopsin-expressing ZI axons in wild-type mice in an awake in vivo preparation. Stimulation with short single pulses and trains of stimulation at 20 Hz evoked rapid responses in most recorded cells in both the PN and IO. Furthermore, the excitatory responses of PN neurons were proportional to the strength of ZI activation. Next, synaptic transmission at ZI-IO synapses was investigated using in vitro electrophysiology. Optogenetic activation of ZI axons elicited strong excitatory postsynaptic responses in IO neurons that remained robust to repetitive stimulation at 20 Hz. Overall, these results demonstrate a functional connection between the ZI-PN and ZI-IO pathways.
First, the presence of ZI projections to PNs was confirmed by injecting an adeno-associated virus expressing the excitatory opsin channelrhodopsin (ChR2) and a yellow fluorescent protein (YFP) reporter (AAV2-hSyn-ChR2 (H134R)-eYFP) into the ZI of wild-type C57BL/6 mice. Histological results showed the presence of ZI axons expressing ChR2 in PNs. Then, optodes were used to record extracellular unit activity in PNs of awake, head-restrained mice while stimulating ZI axons expressing ChR2 with 1-ms pulses of blue light (Figure 1A). Activation of ChR2-expressing axons near the recording site rapidly altered the firing of 77% of the PN neurons examined (Figure 1B). Three response types were observed: excitation (Ex), excitation followed by inhibition (Ex + In), and inhibition (In) (Figures 1B and 1C). Unresponsive cells were categorized as "no response" (Figure 1C). The mean latency of excitation (including inhibition after the excitation peak) was 2.39 ± 0.2 ms (Figure 1D), while the mean latency of inhibition was 2.8 ± 0.49 ms (Figure 1E). Together, these results confirm that ZI fiber activation can rapidly elicit responses in PN neurons.
Figure 1. A rapid short-duration optogenetic activation of zona incerta axons reliably elicits responses in the pontine nuclei. (Bhuvanasundaram R, et al., 2024)
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
The AAV2-hSyn-ChR2(H134R)-YFP has been a game-changer for our optogenetics studies. Its efficient gene delivery into neurons has significantly boosted our experimental throughput.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.